[Antiulcer prevention in urological practice]
Abstract:
This article is a detailed analysis of the studies of Russian and foreign authors on the epidemiology, clinical features, pathogenesis, risk factors of stress-induced disease of the mucosa of the upper gastrointestinal tract. Also in the article the approaches to drug prevention of this complication are considered. Currently, there are several groups of drugs are suitable for use for this purpose. However, the choice of a specific drug is difficult because of insufficient knowledge of the matter. Data on the incidence and natural history of erosive and ulcerative complications in patients urological profile is limited and very controversial.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...


